AMWL

American Well Corp
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$228.43M
P/E Ratio
—
EPS
$-4.78
Beta
1.71
52W High
$14.19
52W Low
$3.71
50-Day MA
$12.36
200-Day MA
$7.84
Dividend Yield
—
Profit Margin
-35.70%
Forward P/E
—
PEG Ratio
—

About American Well Corp

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$218.53M
Gross Profit (TTM)$114.91M
EBITDA$-39.89M
Operating Margin-19.60%
Return on Equity-29.10%
Return on Assets-12.70%
Revenue/Share (TTM)$13.25
Book Value$13.07
Price-to-Book1.02
Price-to-Sales (TTM)1.04
EV/Revenue0.145
EV/EBITDA-0.81
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-26.60%
Shares Outstanding$15.36M
Float$11.93M
% Insiders5.39%
% Institutions50.83%

Historical Volatility

HV 10-Day
43.43%
HV 20-Day
52.15%
HV 30-Day
48.55%
HV 60-Day
81.39%
HV Rank
20.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($12.80 target)
1
Buy
6
Hold

Latest News

Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure

BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA's digital health infrastructure.

GlobeNewsWire9/8/2026Neutral
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

GlobeNewsWire9/3/2026Neutral
Amwell® to participate in upcoming investor conferences

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

GlobeNewsWire9/2/2026Neutral
Amwell makes grant to new employees under inducement plan

BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwell made grants of RSUs covering an aggregate of 6,679 shares of its Class A common stock to two new non-executive employees. The grants were offered as material inducement to the employees' entry into employment with Amwell.

GlobeNewsWire8/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMWL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/26/2026